Mechanisms leading to expression of Tn and STn O-glycans in cancers include somatic mutations and/or epigenetic silencing of the private chaperone Cosmc responsible for O-glycan elongation10 as well as relocation of GalNAc-Ts from Golgi to endoplasmic reticulum11. Here, EEF1A2 is linked to cancer.